Benjie Wang, PhD

Phase 1 Clinical Trial Center, Qilu Hospital of Shandong University; NMPA Key Laboratory for Clinical Research and Evaluation of Innovative Drugs, China

Poster(s):

• (2553) Safety, tolerability and pharmacokinetics of HS-10366 in healthy Chinese subjects: A randomized, double-blind, placebo-controlled phase 1 trial.
  Saturday, October 14, 2023

  12:15 PM – 1:30 PM US ET